Posts Tagged ‘death rates’

Lunf Cancer Soon to Overtake Breast Cancer as the Main Cause of Cancer Deaths in European Women

Friday, February 22nd, 2013

logo1267406_mdA new article in the Annals of Oncology concluded that lung cancer is likely to overtake breast cancer as the main cause of cancer deaths among European women by the middle of this decade and that it has already happened in the UK and Poland.

The study looked at cancer rates in the whole of the European Union (27 member states in 2007) and six individual countries (France, Germany, Italy, Poland, Spain, and UK). for all cancers, and individually for stomach, intestine, pancreas, lung, prostate, breast, uterus (including cervix), and leukemia. This is their third year of publishing predicted EU cancer deaths and this year they focused on intestinal cancers, particularly colorectal cancers and found a drop in rates for these cancer when compared to 2005-2009. Variations by country were noted in the research.

From previous data they found that the overall rate of cancer deaths have dropped but lung cancer rates continue to rise among women while breast cancer rates decline. In 2013 there will be a breast cancer rate for women among this population of 14.6 per 100,000 while the lung cancer rate will be 14 per 100,000 representing a 7% increase in lung cancer among women since 2009.  The researcher said “If these opposite trends in breast and lung cancer rates continue, then in 2015 `lung cancer is going to become the first cause of cancer mortality in Europe. This is already true in the UK and Poland, the two countries with the highest rates: 21.2 and 17.5 per 100,000 women respectively.”

It is believed that the rise in lung cancer rates are related to increased smoking among this population.

Aspirin May Reduce Deaths after Treatment for Breast Cancer

Friday, February 26th, 2010

logo1267406_md

A study in the Journal of Clinical Oncology reported that “aspirin can significantly reduce the risk of cancer spread and death in women who have been treated for early breast cancer.” Researchers at Harvard Medical School studied 4,164 female registered nurses taking part in the Nurses’ Health Study. Starting in 1976 they looked at who took aspirin, who developed breast cancer and all causes of death up until 2006. During this time 341 nurses died of breast cancer. Of this group women who took aspirin two to five days a week had a 60% reduced risk of their cancer spreading and a 71% lower risk of breast cancer death. Other non-steroidal inflammatory drugs (NSAID’s) in the same class as aspirin had the same effect and included ibuprofen and naproxen but not acetaminophen. This relationship was not as clear because of limited data. Although aspirin is relatively benign compared with chemotherapy drugs it can cause bleeding and should not be taken without medical supervision. It also should not be taken while undergoing chemotherapy or radiation therapy because of the possible side effects.

Is It Beneficial to a Woman’s Health to Remove Her Ovaries during a Hysterectomy?

Wednesday, July 22nd, 2009

logo1267406_md

In the past it has been common practice to remove both of a woman’s ovaries during a hysterectomy to eliminate the possibility of later ovarian cancer. Now researchers at St Johns Health Center in Santa Monica, California results question this practice because although it does decrease ovarian and breast cancers it also increases the risk of death. In “Ovarian Conservation at the Time of Hysterectomy and Long Term Health Outcomes in the Nurses’ Health Study” published in the May 2009 issue of Obstetrics and Gynecology researchers questioned the practice because ovarian cancer has a low risk of about 3% and is responsible for less than 1% of all deaths among women. In their study they focused on a set of 29,380 women who had been followed for years of which 13,035 had hysterectomies without their ovaries removed, and 16,345 had hysterectomies with their ovaries removed. They evaluated deaths and incident events from coronary heart disease, stroke, breast cancer, ovarian cancer, lung cancer, colorectal cancer, total cancers, hip fractures, pulmonary embolus, and death from all causes. Women were separated into pre and post menopausal groups at the time of hysterectomies and those who had estrogen replacvement therapy were identified.
After adjusting for multiple independent risk factors, the researchers found the following trends: Removal of both ovaries was associated with a markedly lower risk of ovarian. breast cancer and overall cancer. However, they also had a higher risk of coronary heart disease, stroke, and lung cancer. They also had a higher risk of death from coronary heart disease, lung cancer and all cancers. The researchers concluded that at least one in every 24 women having her ovaries removed will die prematurely from any cause as a result of the procedure.
The death rate for women who did not have their ovaries removed was very low: 34 deaths out of 13,305 or 0.26%
More information can be found in the original article.